Professor in the Life Sciences in the department of Molecular Biology at Princeton University. Although his publications have contributed to the fields of biochemistry, cell biology, genetics, genomics, microbiology and virology, his present research interest involves the cytomegalovirus. Aside from academic involvement, Dr. Shenk currently sits on the board of directors of Merck & Co. and the Fox Chase Cancer Center.